Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 18, 2023

SELL
$191.51 - $216.16 $16,661 - $18,805
-87 Reduced 66.41%
44 $9,000
Q2 2023

Jul 28, 2023

BUY
$187.64 - $206.25 $11,446 - $12,581
61 Added 87.14%
131 $25,000
Q1 2023

Apr 12, 2023

SELL
$127.59 - $203.08 $3,189 - $5,077
-25 Reduced 26.32%
70 $14,000
Q4 2022

Jan 18, 2023

BUY
$117.37 - $139.17 $11,150 - $13,221
95 New
95 $0
Q2 2022

Sep 16, 2022

BUY
$108.81 - $179.33 $11,969 - $19,726
110 New
110 $19,000

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Private Trust CO Na Portfolio

Follow Private Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Private Trust CO Na with notifications on news.